A phase II multi-arm study of durvalumab and tremelimumab for advanced or metastatic sarcomas.
暂无分享，去创建一个
I. Wistuba | A. Lazar | P. Hwu | C. Roland | T. Tate | A. Futreal | R. Benjamin | B. Amini | N. Daw | Shreyaskumar R Patel | Wei-Lien Wang | V. Ravi | S. Sabir | Heather Y. Lin | N. Somaiah | R. Ratan | A. Conley | D. Araujo | M. Zarzour | J. Livingston